Ajanta Pharma USA Inc. till date has received twenty one ANDA final approvals and two ANDA tentative approvals from US Food and Drug Administration (FDA).

Currently, sixteen ANDAs are under review with the FDA.

Ajanta is poised to submit over twelve to fifteen ANDAs annually, ensuring a strong, consistent pipeline to fuel growth.

For list of products click here